Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 57

Sort by

Sort Order Select

Journal Articles

B-cell receptor signaling and genetic lesions in TP53 and CDKN2A/CDKN2B cooperate in Richter transformation

Supriya Chakraborty, Claudio Martines, Fabiola Porro, Ilaria Fortunati, Alice Bonato, Marija Dimishkovska, Silvano Piazza, Brijesh S. Yadav, Idanna Innocenti, Rosa Fazio, Tiziana Vaisitti, Silvia Deaglio, Alberto Zamò, Aleksandar J. Dimovski, Luca Laurenti, Dimitar G. Efremov

Blood (2021) 138 (12): 1053–1066.

https://doi.org/10.1182/blood.2020008276

Published: 2021

Includes: Supplemental data

Journal Articles

Gfi1 Upregulates c-Myc Expression and Promotes c-Myc-Driven Cell Proliferation

Yangyang Zhang, MD, Fan Dong, MD PhD

Blood (2019) 134 (Supplement_1): 3769.

https://doi.org/10.1182/blood-2019-124833

Published: 2019

Journal Articles

The Role of the BMP Pathway in Sustaining CML Stem Cells in the Bone Marrow Niche

Caroline Busch, BSc, MSc, Chloe Gulliver, BSc, MSc, Theresa Mulholland, BSc, Michele Zagnoni, BSc, MSc, PhD, Catherine C. Berry, BSc,PhD, Helen Wheadon, BSc, PhD

Blood (2019) 134 (Supplement_1): 3732.

https://doi.org/10.1182/blood-2019-123967

Published: 2019

Journal Articles

Impact of Clinical Features, Cytogenetics, Genetic Mutations and Methylation of CDKN2B and DLC-1 Promoters on Treatment Response to Azacitidine

Iván Martín, Alicia Serrano, Blanca Navarro, MD PhD, Eva Villamón, PhD, Marisa Calabuig, MD, Juan Carlos Hernandez Boluda, Javier F Chaves, PhD, María Isabel Orts, MD, Nuria Yagüe, Paula Amat, MD PhD, Fernando Domingo, Yoana Hernández, Paula Coll, Azahara Fuentes, Enrique Seda, Francisca García, Angeles Muñoz, Carlos Solano, MD PhD, Mar Tormo

Blood (2019) 134 (Supplement_1): 5412.

https://doi.org/10.1182/blood-2019-129019

Published: 2019

Journal Articles

Impact of Genemutations and Dynamics Methylation of CDKN2B and DLC-1 Promoters on Treatment Response with Azacitidine

Iván Martín, Alicia Serrano, Blanca Navarro, MDPhD, Eva Villamón, PhD, Pilar Rentero-Garrido, Fernando Domingo, Javier F Chaves, PhD, Victoria Adam, Paula Amat, MDPhD, Marisa Calabuig, MD, Francisca García, Carlos Solano, MD PhD, Mar Tormo, MD PhD

Blood (2017) 130 (Supplement 1): 3932.

https://doi.org/10.1182/blood.V130.Suppl_1.3932.3932

Published: 2017

Journal Articles

Personalized Therapy Design for Early T-Cell Precursor Acute Lymphoblastic Leukemia (ETP-ALL) Using Computational Biology Modeling with in Vitro Validation

Madeleine Turcotte, MS, Raphael Charles Bosse, BS, MD PhD, Kimberly E. Hawkins, PhD BS, Amy Meacham, MS, Vindhya Vijay, MS, Girish Chinnaswamy, MD MRCP, Manju Sengar, MD DM, Ansu Kumar, MS, Shwetha K, BE, Anisha Kamath, BT, Anjana T. Nair, MS, Karthik S. Raju, MS, Taher Abbasi, MS, MBA, Shireen Vali, PhD, Christopher R. Cogle, MD, Leylah M. Drusbosky, PhD

Blood (2017) 130 (Supplement 1): 1448.

https://doi.org/10.1182/blood.V130.Suppl_1.1448.1448

Published: 2017

Journal Articles

Inhibition of the Epigenetic Modifier EZH2 Upregulates Cell Cycle Control Genes to Inhibit Myeloma Cell Growth and Overcome High-Risk Disease Features

Charlotte Pawlyn, MB BChir, Michael Bright, PhD, Amy Buros, PhD, Caleb K. Stein, MS, Zoe Walters, PhD, Lauren Aronson, PhD, Fabio Mirabella, PhD, Martin F Kaiser, MD, John R Jones, MD, Brian A Walker, PhD, Graham H Jackson, MD PhD, Paul Clarke, PhD, Leif Bergsagel, MD, Paul Workman, PhD, Marta Chesi, PhD, Gareth J Morgan, MD PhD, Faith E Davies, MD

Blood (2016) 128 (22): 3289.

https://doi.org/10.1182/blood.V128.22.3289.3289

Published: 2016

Journal Articles

CDKN2 Gene Deletion As Poor Prognosis Predictor Involving in the Progression of Adult B-Lineage Acute Lymphoblastic Leukemia Patients

Yuling Li, Na Xu, MD, Xuan Zhou, MD, Jixian Huang, Lin Li, Qisi Lu, Ziyuan Lu, Bolin He, Chengyun Pan, Qifa Liu, MD, Liu Xiaoli, MD

Blood (2015) 126 (23): 4806.

https://doi.org/10.1182/blood.V126.23.4806.4806

Published: 2015

Journal Articles

Analysis of Copy Number Abnormalities of 86 Acute Lymphoblastic Leukemia Cell Lines Based on the Genetic Subtypes

Chihiro Tomoyasu, MD, Toshihiko Imamura, MD, Mio Yano, MD, Daisuke Asai, MD, Meixian Huang, MD, Hiroaki Goto, MD PhD, Akira Shimada, MD PhD, Takeshi Inukai, MD PhD, Kanji Sugita, MD PhD, Hajime Hosoi, MD

Blood (2015) 126 (23): 1424.

https://doi.org/10.1182/blood.V126.23.1424.1424

Published: 2015

Journal Articles

Down-Regulation of HO-1 Promoted Apoptosis Induced By Decitabine Via Increasing p15 INK4B Promoter Demethylation in myelodysplastic syndrome

Jishi Wang, Dan Ma, MDcine Doctor, Qin Fang, Ping Wang, Rui Gao, Jia Sun

Blood (2014) 124 (21): 5213.

https://doi.org/10.1182/blood.V124.21.5213.5213

Published: 2014

Journal Articles

Analysis of CpG Island DNA Methylation of p15 INK4b and RIL in Bone Marrow Samples of Patients with Monoclonal Gammopathies

Pavla Latalova, MD, Katerina Smesny Trtkova, Ing., Lucie Navratilova, Mgr, Vlastimil Scudla, prof, MD PhD, Jiri Minarik, MD PhD

Blood (2014) 124 (21): 5174.

https://doi.org/10.1182/blood.V124.21.5174.5174

Published: 2014

Journal Articles

The Strong Prognostic Effect of Concurrent Deletions of IKZF1 and PAX5 , CDKN2A , CDKN2B or PAR1 in the Absence of ERG Deletions (IKZF1 plus ) in Pediatric Acute Lymphoblastic Leukemia Strongly Depends on Minimal Residual Disease Burden after Induction Treatment

Blood (2014) 124 (21): 131.

https://doi.org/10.1182/blood.V124.21.131.131

Published: 2014

Journal Articles

CLL Mesenchymal Stromal Cells Have Decreased Replicative Potential and Senescent Phenotype: Clinical and Biologic Implications

Wei Ding, MD PhD, Charla Secreto, Xiaosheng Wu, PhD, Esteban Braggio, PhD, Yuji Zhang, PhD, Stephanie A. Smoley, Tait D. Shanafelt, MD, Jaime Davila, PhD, Timothy G Call, MD, Daniel L. Van Dyke, PhD, Diane F. Jelinek, Neil E. Kay, MD

Blood (2014) 124 (21): 3282.

https://doi.org/10.1182/blood.V124.21.3282.3282

Published: 2014

Journal Articles

High Resolution Genomic Profiling of Primary “Ultra High Risk” and Refractory Chronic Lymphocytic Leukemia: Results from the CLL2O Trial

Jennifer Edelmann, MD, Jenny Saub, Stefan Ibach, Karlheinz Holzmann, PhD, Eugen Tausch, MD, Johannes Bloehdorn, MD, Daniel Mertens, PhD, Thorsten Zenz, MD, Florence Cymbalista, MD, Veronique Leblond, MD PhD, Alain Delmer, MD PhD, John G. Gribben, MD DSc, Michael Hallek, MD, Hartmut Döhner, MD, Stephan Stilgenbauer, MD

Blood (2014) 124 (21): 3288.

https://doi.org/10.1182/blood.V124.21.3288.3288

Published: 2014

Journal Articles

MSH-TP15 Identified By Phage Display Technology Detects a Target Structure For Antibody-Mediated Killing In Multiple Myeloma

Katja Klausz, PhD, Renate Burger, PhD, Christian Kellner, PhD, Pia Glorius, PhD, Andreas Guenther, MD, Matthias Peipp, PhD, Martin Gramatzki, MD

Blood (2013) 122 (21): 4442.

https://doi.org/10.1182/blood.V122.21.4442.4442

Published: 2013

Journal Articles

Immunoglobulin Heavy Chain Locus ( IGH@) Translocations in Childhood B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL): Incidence and Risk Stratification

Lisa J Russell, PhD, Lisa Jones, BSc, Amy Erhorn, PhD, Amir Ensahei, PhD, Dino Masic, MRes, Helen Bentley, Karl S Laczko, Christine J Harrison, PhD, FRCPath

Blood (2012) 120 (21): 1274.

https://doi.org/10.1182/blood.V120.21.1274.1274

Published: 2012

Journal Articles

Maintenance of Osteogenic Differentiation Capacity of MSPC Despite Amplified Proliferation Under Elevated Oxgen Conditions

Katharina Schallmoser, MD, Nicole A Hofmann, MSc, Andreas Reinisch, MD, PhD, Anna Ortner, MSc, Claudia Url, Nathalie Etchart, PhD, Sylvia Joussen, MSc, Wolfgang Wagner, MD, PhD, Dirk Strunk, MD

Blood (2012) 120 (21): 1916.

https://doi.org/10.1182/blood.V120.21.1916.1916

Published: 2012

Journal Articles

IKZF1 Deletion Is Strongly Associated with Risk of Relapse in Pediatric B Cell Precursor ALL with TCF3-PBX1

Daisuke Asai, MD, Toshihiko Imamura, MD, So-ichi Suenobu, MD, Akiko Moriya Saito, MD, Daiichiro Hasegawa, MD, Takao Deguchi, MD, Hashii Yoshiko, MD, Mikiya Endo, MD, Naoki Hatakeyama, MD, Hirohide Kawasaki, MD, Hiroki Hori, MD, Keizo Horibe, MD, Keiko Yagi, MD, Junichi Hara, MD, Megumi Oda, MD, Atsushi Sato, MD

Blood (2012) 120 (21): 1454.

https://doi.org/10.1182/blood.V120.21.1454.1454

Published: 2012

Journal Articles

DNMT3A Mutations Are Connected with Lower DNA Methylation Levels and Numbers of Concurrently Hypermethylated Genes in AML Patients

Hana Hajkova, Jana Markova, Cedrik Haskovec, PhD, Jaroslav Cermak, Radka Petrbokova, Kyra Michalova, PhD, Jiri Schwarz, MD, PhD

Blood (2011) 118 (21): 4629.

https://doi.org/10.1182/blood.V118.21.4629.4629

Published: 2011

Journal Articles

KDM2b/JHDM1b, an H3K36me2-specific demethylase, is required for initiation and maintenance of acute myeloid leukemia

Jin He, Anh Tram Nguyen, Yi Zhang

Blood (2011) 117 (14): 3869–3880.

https://doi.org/10.1182/blood-2010-10-312736

Published: 2011

Includes: Supplemental data

NARROW

B-cell receptor signaling and genetic lesions in TP53 and CDKN2A/CDKN2B cooperate in Richter transformation

Gfi1 Upregulates c-Myc Expression and Promotes c-Myc-Driven Cell Proliferation

The Role of the BMP Pathway in Sustaining CML Stem Cells in the Bone Marrow Niche

Impact of Clinical Features, Cytogenetics, Genetic Mutations and Methylation of CDKN2B and DLC-1 Promoters on Treatment Response to Azacitidine

Impact of Genemutations and Dynamics Methylation of CDKN2B and DLC-1 Promoters on Treatment Response with Azacitidine

Personalized Therapy Design for Early T-Cell Precursor Acute Lymphoblastic Leukemia (ETP-ALL) Using Computational Biology Modeling with in Vitro Validation

Inhibition of the Epigenetic Modifier EZH2 Upregulates Cell Cycle Control Genes to Inhibit Myeloma Cell Growth and Overcome High-Risk Disease Features

CDKN2 Gene Deletion As Poor Prognosis Predictor Involving in the Progression of Adult B-Lineage Acute Lymphoblastic Leukemia Patients

Analysis of Copy Number Abnormalities of 86 Acute Lymphoblastic Leukemia Cell Lines Based on the Genetic Subtypes

Down-Regulation of HO-1 Promoted Apoptosis Induced By Decitabine Via Increasing p15 INK4B Promoter Demethylation in myelodysplastic syndrome

Analysis of CpG Island DNA Methylation of p15 INK4b and RIL in Bone Marrow Samples of Patients with Monoclonal Gammopathies

The Strong Prognostic Effect of Concurrent Deletions of IKZF1 and PAX5 , CDKN2A , CDKN2B or PAR1 in the Absence of ERG Deletions (IKZF1 plus ) in Pediatric Acute Lymphoblastic Leukemia Strongly Depends on Minimal Residual Disease Burden after Induction Treatment

CLL Mesenchymal Stromal Cells Have Decreased Replicative Potential and Senescent Phenotype: Clinical and Biologic Implications

High Resolution Genomic Profiling of Primary “Ultra High Risk” and Refractory Chronic Lymphocytic Leukemia: Results from the CLL2O Trial

MSH-TP15 Identified By Phage Display Technology Detects a Target Structure For Antibody-Mediated Killing In Multiple Myeloma

Immunoglobulin Heavy Chain Locus ( IGH@) Translocations in Childhood B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL): Incidence and Risk Stratification

Maintenance of Osteogenic Differentiation Capacity of MSPC Despite Amplified Proliferation Under Elevated Oxgen Conditions

IKZF1 Deletion Is Strongly Associated with Risk of Relapse in Pediatric B Cell Precursor ALL with TCF3-PBX1

DNMT3A Mutations Are Connected with Lower DNA Methylation Levels and Numbers of Concurrently Hypermethylated Genes in AML Patients

KDM2b/JHDM1b, an H3K36me2-specific demethylase, is required for initiation and maintenance of acute myeloid leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only